Hunan Hansen Pharmaceutical Co. Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000PK2
CNY
7.03
0.1 (1.44%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
984.42
936.62
898.09
873.89
726.92
869.86
903.38
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
984.42
936.62
898.09
873.89
726.92
869.86
903.38
Raw Material Cost
256.56
272.55
272.23
263.23
237.59
250.19
254.23
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
178.99
167.27
137.59
134.12
108.85
126.51
141.64
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.87
3.89
4.11
6.85
7.44
10.32
13.51
Selling and Distribution Expenses
456.07
451.77
444.50
444.39
371.86
398.13
465.30
Other Expenses
-14.39
-12.88
-9.38
-10.15
-8.51
-10.34
-11.87
Total Expenditure (Excl Depreciation)
750.61
766.70
764.64
747.07
640.68
681.77
755.97
Operating Profit (PBDIT) excl Other Income
233.79999999999998
169.89999999999998
133.4
126.8
86.19999999999999
188.1
147.4
Other Income
9.68
9.59
1.73
4.04
11.62
9.92
8.95
Operating Profit (PBDIT)
287.70
231.12
187.24
182.04
148.17
246.38
202.72
Interest
2.87
3.89
4.11
6.85
7.44
10.32
13.51
Exceptional Items
2.07
-7.28
-39.50
-40.42
-25.85
-46.12
0.00
Gross Profit (PBDT)
727.87
664.08
625.85
610.66
489.32
619.66
649.16
Depreciation
41.48
51.68
52.30
51.70
50.61
48.32
46.25
Profit Before Tax
245.42
168.27
91.32
83.06
64.27
141.62
142.95
Tax
32.51
21.00
14.24
15.05
11.49
26.41
18.35
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
220.24
205.01
167.62
134.85
106.15
162.38
147.54
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
220.24
205.01
167.62
134.85
106.15
162.38
147.54
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
220.24
205.01
167.62
134.85
106.15
162.38
147.54
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,203.38
1,963.03
1,894.13
1,742.29
1,594.72
1,529.98
1,373.65
Earnings per share (EPS)
0.44
0.41
0.33
0.27
0.21
0.32
0.29
Diluted Earnings per share
0.44
0.41
0.33
0.27
0.21
0.32
0.29
Operating Profit Margin (Excl OI)
24.03%
18.13%
14.83%
14.45%
11.82%
21.63%
16.33%
Gross Profit Margin
29.14%
23.48%
15.99%
15.42%
15.8%
21.84%
20.94%
PAT Margin
22.37%
21.89%
18.66%
15.43%
14.6%
18.67%
16.33%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 5.10% vs 4.29% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 7.41% vs 22.32% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 25.51% vs 19.41% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -25.64% vs -4.88% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Hunan Hansen Pharmaceutical Co. Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
984.42
0
984.42
Other Operating Income
0.00
0.00
0.00
Total Operating income
984.42
0
984.42
Raw Material Cost
256.56
0
256.56
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
178.99
0
178.99
Power Cost
0
0
0.00
Manufacturing Expenses
2.87
0
2.87
Selling and Distribution Expenses
456.07
0
456.07
Other Expenses
-14.39
0.00
-14.39
Total Expenditure (Excl Depreciation)
750.61
0
750.61
Operating Profit (PBDIT) excl Other Income
233.81
0.00
233.81
Other Income
9.68
0
9.68
Operating Profit (PBDIT)
287.70
0
287.70
Interest
2.87
0
2.87
Exceptional Items
2.07
0
2.07
Gross Profit (PBDT)
727.87
0
727.87
Depreciation
41.48
0
41.48
Profit Before Tax
245.42
0
245.42
Tax
32.51
0
32.51
Provisions and contingencies
0
0
0.00
Profit After Tax
220.24
0
220.24
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
220.24
0
220.24
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
220.24
0
220.24
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,203.38
0
2,203.38
Earnings per share (EPS)
0.44
0
0.44
Diluted Earnings per share
0.44
0
0.44
Operating Profit Margin (Excl OI)
24.03%
0%
0.00
24.03%
Gross Profit Margin
29.14%
0%
0.00
29.14%
PAT Margin
22.37%
0%
0.00
22.37%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 98.44 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 5.10% vs 4.29% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 22.02 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 7.41% vs 22.32% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 27.80 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 25.51% vs 19.41% in Dec 2023

Annual - Interest
Interest 0.29 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -25.64% vs -4.88% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.03%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023